Back to top
more

Zynex (ZYXI)

(Delayed Data from NSDQ)

$8.92 USD

8.92
93,799

0.00 (0.00%)

Updated Jul 5, 2024 04:00 PM ET

After-Market: $8.93 +0.01 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 249)

Industry: Medical - Products

Better trading starts here.

Zacks News

Nalak Das headshot

5 Stocks With Recent Price Strength Amid Disappointing Data

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Ritujay Ghosh headshot

Trump Pushes for US-Made Medical Products: 4 Winners

An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.

Top Ranked Momentum Stocks to Buy for May 5th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 5th

Tirthankar Chakraborty headshot

New Strong Buy Stocks for May 4th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

Will Zynex Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Zynex

Zynex Sees Hammer Chart Pattern: Time to Buy?

Zynex has been struggling lately, but the selling pressure may be coming to an end soon.

Sanghamitra Saha headshot

5 DuPont-Tested High Quality Stock Picks as Virus Scare Spreads

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

Top Ranked Momentum Stocks to Buy for February 28th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 28th

Zynex, Inc. (ZYXI) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Zynex, Inc. (ZYXI).

Urmimala Biswas headshot

3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Zynex (ZYXI) Scales 52-Week High: What's Driving the Stock?

Zynex (ZYXI) is likely to maintain the current high on a number of favorable factors.

Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?

Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.